Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

9,180

Participants

Timeline

Start Date

February 7, 2023

Primary Completion Date

January 31, 2027

Study Completion Date

June 30, 2027

Conditions
Surgical Site Infection
Interventions
DRUG

Cefazolin

Intravenous administration of 2 g cefazolin

DRUG

Water for injection

Intravenous administration of 10mL sterile water for injection

Trial Locations (22)

2145

RECRUITING

Westmead Hospital, Sydney

2217

ACTIVE_NOT_RECRUITING

St George Hospital, Sydney

3004

RECRUITING

The Alfred Hospital, Melbourne

3050

NOT_YET_RECRUITING

The Royal Melbourne Hospital, Melbourne

3084

NOT_YET_RECRUITING

Austin Health, Melbourne

3121

NOT_YET_RECRUITING

Epworth HealthCare, Melbourne

3128

NOT_YET_RECRUITING

Epworth Eastern HealthCare, Melbourne

3144

NOT_YET_RECRUITING

Cabrini Health, Melbourne

3168

RECRUITING

Victorian Heart Hospital, Melbourne

3204

NOT_YET_RECRUITING

Waikato Hospital, Hamilton

4032

RECRUITING

The Prince Charles Hospital, Brisbane

4102

NOT_YET_RECRUITING

Princess Alexandra Hospital, Brisbane

5000

NOT_YET_RECRUITING

Royal Adelaide Hospital, Adelaide

5042

NOT_YET_RECRUITING

Flinders Medical Centre, Adelaide

NOT_YET_RECRUITING

Flinders Private, Adelaide

6008

RECRUITING

St John of God Subiaco Hospital, Perth

7000

NOT_YET_RECRUITING

Royal Hobart Hospital, Hobart

Unknown

NOT_YET_RECRUITING

Sir Charles Gairdner, Nedlands

NOT_YET_RECRUITING

Fiona Stanley Hospital, Perth

NOT_YET_RECRUITING

St Vincent's Hospital, Melbourne

RECRUITING

Christchurch Hospital, Christchurch

RECRUITING

Wellington Hospital, Wellington

All Listed Sponsors
collaborator

The Australian and New Zealand College of Anaesthetists (ANZCA)

UNKNOWN

lead

Monash University

OTHER